Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay.

Taylor AW, Dawson ED, Blair RH, Johnson JE Jr, Slinskey AH, Smolak AW, Toth E, Liikanen K, Stoughton RS, Smith C, Talbot S, Rowlen KL.

J Virol Methods. 2019 Jul 1:113686. doi: 10.1016/j.jviromet.2019.113686. [Epub ahead of print]

PMID:
31271790
2.

Establishment of a low birth weight registry and initial outcomes.

Eisenhauer E, Uddin DE, Albers P, Paton S, Stoughton RL.

Matern Child Health J. 2011 Oct;15(7):921-30. doi: 10.1007/s10995-009-0540-8.

PMID:
19908132
3.

Applications of DNA microarrays in biology.

Stoughton RB.

Annu Rev Biochem. 2005;74:53-82. Review.

PMID:
15952881
4.

How molecular profiling is transforming drug discovery.

Stoughton RB.

Discov Med. 2005 Jun;5(27):247-52.

5.

A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients.

Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S.

Cancer Res. 2005 May 15;65(10):4059-66.

6.

How molecular profiling could revolutionize drug discovery.

Stoughton RB, Friend SH.

Nat Rev Drug Discov. 2005 Apr;4(4):345-50. Review.

PMID:
15789121
7.

Integrated genomic and proteomic analyses of gene expression in Mammalian cells.

Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE.

Mol Cell Proteomics. 2004 Oct;3(10):960-9. Epub 2004 Jul 6.

8.

Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.

Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD.

Science. 2003 Dec 19;302(5653):2141-4.

9.

Effects of atmospheric ozone on microarray data quality.

Fare TL, Coffey EM, Dai H, He YD, Kessler DA, Kilian KA, Koch JE, LeProust E, Marton MJ, Meyer MR, Stoughton RB, Tokiwa GY, Wang Y.

Anal Chem. 2003 Sep 1;75(17):4672-5.

PMID:
14632079
10.

Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing.

Castle J, Garrett-Engele P, Armour CD, Duenwald SJ, Loerch PM, Meyer MR, Schadt EE, Stoughton R, Parrish ML, Shoemaker DD, Johnson JM.

Genome Biol. 2003;4(10):R66. Epub 2003 Sep 19.

11.

Microarray standard data set and figures of merit for comparing data processing methods and experiment designs.

He YD, Dai H, Schadt EE, Cavet G, Edwards SW, Stepaniants SB, Duenwald S, Kleinhanz R, Jones AR, Shoemaker DD, Stoughton RB.

Bioinformatics. 2003 May 22;19(8):956-65.

PMID:
12761058
12.

Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences.

Waring JF, Cavet G, Jolly RA, McDowell J, Dai H, Ciurlionis R, Zhang C, Stoughton R, Lum P, Ferguson A, Roberts CJ, Ulrich RG.

EHP Toxicogenomics. 2003 Jan;111(1T):53-60.

PMID:
12735110
13.

Genetics of gene expression surveyed in maize, mouse and man.

Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB, Friend SH.

Nature. 2003 Mar 20;422(6929):297-302.

PMID:
12646919
14.

Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays.

Dai H, Meyer M, Stepaniants S, Ziman M, Stoughton R.

Nucleic Acids Res. 2002 Aug 15;30(16):e86.

15.

Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters.

Wu LF, Hughes TR, Davierwala AP, Robinson MD, Stoughton R, Altschuler SJ.

Nat Genet. 2002 Jul;31(3):255-65. Epub 2002 Jun 24.

PMID:
12089522
16.

The magic of microarrays.

Friend SH, Stoughton RB.

Sci Am. 2002 Feb;286(2):44-9, 53. No abstract available.

PMID:
11828700
17.

Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer.

Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR, Kobayashi S, Davis C, Dai H, He YD, Stephaniants SB, Cavet G, Walker WL, West A, Coffey E, Shoemaker DD, Stoughton R, Blanchard AP, Friend SH, Linsley PS.

Nat Biotechnol. 2001 Apr;19(4):342-7.

PMID:
11283592
18.

Experimental annotation of the human genome using microarray technology.

Shoemaker DD, Schadt EE, Armour CD, He YD, Garrett-Engele P, McDonagh PD, Loerch PM, Leonardson A, Lum PY, Cavet G, Wu LF, Altschuler SJ, Edwards S, King J, Tsang JS, Schimmack G, Schelter JM, Koch J, Ziman M, Marton MJ, Li B, Cundiff P, Ward T, Castle J, Krolewski M, Meyer MR, Mao M, Burchard J, Kidd MJ, Dai H, Phillips JW, Linsley PS, Stoughton R, Scherer S, Boguski MS.

Nature. 2001 Feb 15;409(6822):922-7.

PMID:
11237012
19.

Functional discovery via a compendium of expression profiles.

Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ, King AM, Meyer MR, Slade D, Lum PY, Stepaniants SB, Shoemaker DD, Gachotte D, Chakraburtty K, Simon J, Bard M, Friend SH.

Cell. 2000 Jul 7;102(1):109-26.

20.

Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.

Roberts CJ, Nelson B, Marton MJ, Stoughton R, Meyer MR, Bennett HA, He YD, Dai H, Walker WL, Hughes TR, Tyers M, Boone C, Friend SH.

Science. 2000 Feb 4;287(5454):873-80.

21.

Drug target validation and identification of secondary drug target effects using DNA microarrays.

Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE Jr, Hartwell LH, Brown PO, Friend SH.

Nat Med. 1998 Nov;4(11):1293-301.

PMID:
9809554
22.

Data-adaptive algorithms for calling alleles in repeat polymorphisms.

Stoughton R, Bumgarner R, Frederick WJ 3rd, McIndoe RA.

Electrophoresis. 1997 Jan;18(1):1-5.

PMID:
9059812
23.
24.

Release of vasopressin in response to altered plasma volume and sodium concentrations following pinealectomy in the rat.

Forsling ML, Stoughton R, Kelestimur H, Kostoglou-Athanassiou I, Demaine C.

J Pineal Res. 1996 May;20(4):211-6.

PMID:
8836955
25.

The role of the pineal in the control of the daily patterns of neurohypophysial hormone secretion.

Forsling ML, Stoughton RP, Zhou Y, Kelestimur H, Demaine C.

J Pineal Res. 1993 Jan;14(1):45-51.

PMID:
8483105
26.

The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.

Stoughton RB.

Int J Dermatol. 1992 Oct;31 Suppl 1:26-8. Review.

PMID:
1428464
27.

Relation of application time to bioactivity of a potent topical glucocorticoid formulation.

Stoughton RB, Wullich K.

J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1038-41.

PMID:
2370328
28.
29.

In vitro and in vivo cutaneous penetration and antifungal activity of naftifine.

Stoughton RB, Sefton J, Zeleznick L.

Cutis. 1989 Oct;44(4):333-5.

PMID:
2805810
30.

Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.

Aly R, Maibach HI, Bagatell FK, Dittmar W, Hänel H, Falanga V, Leyden JJ, Roth HL, Stoughton RB, Willis I, et al.

Clin Ther. 1989 May-Jun;11(3):290-303.

PMID:
2663159
31.

Percutaneous absorption of drugs.

Stoughton RB.

Annu Rev Pharmacol Toxicol. 1989;29:55-69. Review.

PMID:
2658778
32.

Adrenal suppression following low-dose topical clobetasol propionate.

Stoughton RB.

J R Soc Med. 1988 May;81(5):308. No abstract available.

33.

Erythromycin 2 percent gel in the treatment of acne vulgaris.

Pochi PE, Bagatell FK, Ellis CN, Stoughton RB, Whitmore CG, Saatjian GD, Sefton J.

Cutis. 1988 Feb;41(2):132-6.

PMID:
2964344
34.

Are generic topical glucocorticosteroids equivalent to the brand name?

Stoughton RB.

J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):138-9. No abstract available.

PMID:
3346396
35.

Long-term monitoring of mouse ultrasonic vocalizations.

Warburton VL, Stoughton R, Demaine C, Sales GD, Milligan SR.

Physiol Behav. 1988;44(6):829-31.

PMID:
3249761
36.

Are generic formulations equivalent to trade name topical glucocorticoids?

Stoughton RB.

Arch Dermatol. 1987 Oct;123(10):1312-4.

PMID:
3662563
37.
38.
39.

Correlation of the vasoconstriction assay and clinical activity in psoriasis.

Cornell RC, Stoughton RB.

Arch Dermatol. 1985 Jan;121(1):63-7.

PMID:
3881088
40.

Psoriasis.

Stoughton RB.

West J Med. 1983 Aug;139(2):216. No abstract available.

41.

Monoclonal antibody binding to brain membranes is altered by iodonitrotetrazolium violet treatment.

Stoughton RL, Kelly PT, Akeson R.

Neurosci Lett. 1983 Feb 21;35(2):215-20.

PMID:
6856197
42.

Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one.

Stoughton RB.

Arch Dermatol. 1982 Jul;118(7):474-7.

PMID:
7092271
43.

Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.

Marino C, Stoughton RB.

J Am Acad Dermatol. 1982 May;6(5):902-8. No abstract available.

PMID:
6212602
44.

Topical or systemic antibiotics for acne.

Stoughton RB.

Int J Dermatol. 1981 Nov;20(9):592-3. No abstract available.

PMID:
6458571
45.

Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.

Becker LE, Bergstresser PR, Whiting DA, Clendenning WE, Dobson RL, Jordan WP, Abell E, LeZotte LA, Pochi PE, Shupack JL, Sigafoes RB, Stoughton RB, Voorhees JJ.

Arch Dermatol. 1981 Aug;117(8):482-5.

PMID:
6455095
46.
47.

Topical drug effects on normal and proliferating epidermal cell models.

Lowe NJ, Stoughton RB, McCullough JL, Weinstein GD.

Arch Dermatol. 1981 Jul;117(7):394-8.

PMID:
7259217
48.

A clinical screening program for topical chemotherapeutic drugs in psoriasis.

Weinstein GD, McCullough JL, Eaglstein WH, Golub A, Cornell RC, Stoughton RB, Clendenning W, Zackheim H, Maibach H, Kulp KR, King L, Baden HP, Taylor JS, Deneau DD.

Arch Dermatol. 1981 Jul;117(7):388-93.

PMID:
6789777
49.
50.

What's new.

Stoughton RB.

J Am Acad Dermatol. 1980 May;2(5):411-6. Review. No abstract available.

PMID:
6155388

Supplemental Content

Loading ...
Support Center